J&J Switches Benacort Hayfever Spray From Rx To GSL Status In The UK
Executive Summary
J&J switches its Benacort hayfever nasal spray from prescription-only to general sales list status in the UK, making it the third mass market steriod-based spray available outside pharmacy.
You may also be interested in...
Sanofi’s Nasacort Hay Fever Spray Latest In Post-Brexit UK Switch Boom
Sanofi's Nasacort Allergy Relief hay fever spray is the latest in a flood of reclassifications in the UK since the beginning of the year when the country left the European Union.
Sanofi Switch Gives UK Hay Fever Sufferers Additional Mass Market Option
Sanofi has switched its Allevia hay fever tablets (fexofenadine hydrochloride) in the UK, from prescription-only to general sales list status.
J&J Leverages Power Of Digital Personalization With Nicorette UK Extension
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.